WHO ICTRP trial
Comparison of the effect of using electromagnetic waves with gabapentin in the…
IRCT20130311012782N62 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20130311012782N62 |
|---|---|
| Public title | Comparison of the effect of using electromagnetic waves with gabapentin in the treatment of tinnitus |
| Scientific title | Evaluation of the efficacy of tinnitus treatment using rTMS compared to gabapentin |
| Primary sponsor | Esfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Tinnitus. Tinnitus;H93.1 |
| Interventions | Intervention 1: Intervention group1: Patients undergo rTMS treatment for 10 sessions every other day (for 20 days). Intervention 2: Intervention group 2: Patients receive 500 mg of gabapentin manufactured by Rozdaro Pharmaceutical Company… |
| Registration date | Dec 11, 2024 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: